drugset / Trial / NCT00202956

Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.

NCT00202956 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis.

Timeline

Start
2004-06
Primary completion
—
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bugusan Unknown — —

Indications